The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 414.80
Bid: 414.80
Ask: 414.90
Change: -6.30 (-1.50%)
Spread: 0.10 (0.024%)
Open: 421.30
High: 424.00
Low: 411.40
Prev. Close: 421.10
RR. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

ROLLS-ROYCE ANNOUNCES AGREEMENTS IN PRINCIPLE

16 Jan 2017 16:54

RNS Number : 2892U
Rolls-Royce Holdings plc
16 January 2017
 

16 January 2017

ROLLS-ROYCE ANNOUNCES AGREEMENTS IN PRINCIPLE

WITH INVESTIGATING AUTHORITIES

 

Rolls-Royce announces that it has in principle reached a Deferred Prosecution Agreement (DPA) with the UK Serious Fraud Office (SFO), which was the subject of a preliminary court ruling today. The proposed DPA is subject to final judicial approval and the SFO and Rolls-Royce will appear at court on 17 January 2017 to seek this approval.

 

In addition to the agreement with the SFO, Rolls-Royce has also reached a DPA with the US Department of Justice (DoJ) and a Leniency Agreement with Brazil's Ministério Público Federal (MPF).

 

Rolls-Royce has co-operated fully with the authorities and will continue to do so.

 

These agreements relate to bribery and corruption involving intermediaries in a number of overseas markets, concerns about which the company passed to the SFO from 2012 onwards. These are voluntary agreements which result in the suspension of a prosecution provided that the company fulfils certain requirements, including the payment of a financial penalty.

 

In total, these agreements, if finalised, would result in the payment of approximately £671m*. Under the terms of the agreements with the DoJ and MPF, Rolls-Royce has agreed to make payments to the DoJ totalling $169,917,710 and to the MPF totalling $25,579,179. Under the terms of the DPA with the SFO, Rolls-Royce will pay £497,252,645 plus interest under a schedule lasting up to five years, plus a payment in respect of the SFO's costs.

 

As a result, total payments by Rolls-Royce in the first year of all three agreements would be £293m*.

 

Rolls-Royce will report full year 2016 results on 14 February 2017 and an appropriate update on the implications of these agreements will be provided at that time. Early indications are that the Group has had a good finish to the year with both profit and, in particular, cash expected to be ahead of expectations.

 

Further details of any finalised agreements will be given at the appropriate time.

 

Today's announcement has been determined to contain inside information.

 

* at current exchange rates

 

About Rolls-Royce Holdings plc

 

1. Rolls-Royce's vision is to be the market-leader in high performance power systems where our engineering expertise, global reach and deep industry knowledge deliver outstanding customer relationships and solutions. We operate across five businesses: Civil Aerospace, Defence Aerospace, Marine, Nuclear and Power Systems.

2. Rolls-Royce has customers in more than 150 countries, comprising more than 400 airlines and leasing customers, 160 armed forces, 4,000 marine customers including 70 navies, and more than 5,000 power and nuclear customers.

3. We have three common themes across all our businesses:

· Investing in and developing engineering excellence

· Driving a manufacturing and supply chain transformation which will embed operational excellence in lean, lower-cost facilities and processes

· Leveraging our installed base, product knowledge and engineering capabilities to provide customers with outstanding service through which we can capture aftermarket value long into the future.

 

4. Annual underlying revenue was £13.4 billion in 2015, around half of which came from the provision of aftermarket services. The firm and announced order book stood at £79.5 billion at the end of June 2016.

5. In 2015, Rolls-Royce invested £1.2 billion on research and development. We also support a global network of 31 University Technology Centres, which position Rolls-Royce engineers at the forefront of scientific research.

6. Rolls-Royce employs over 50,000 people in more than 46 countries. More than 16,000 of these are engineers.

7. The Group has a strong commitment to apprentice and graduate recruitment and to further developing employee skills. In 2015 we employed 228 graduates and 277 apprentices through our worldwide training programmes.

www.Rolls-Royce.com

 

For further information, please contact:

 

Investors

 

John Dawson

Director of Investor Relations

Rolls-Royce plc

Tel: +44 (0)20 7227 9237

investor.relations@rolls-royce.com

 

Helen Harman

Assistant Director, Investor Relations

Rolls-Royce plc

Tel: +44 (0)20 7227 9237

investor.relations@rolls-royce.com

 

Ross Hawley

Assistant Director, Investor Relations

Rolls-Royce plc

Tel: +44 (0)20 7227 9237

investor.relations@rolls-royce.com

 

 

Media

 

Richard Wray Director of External Communications

Rolls-Royce plc

Tel: +44 (0) 20 7227 9163

richard.wray@rolls-royce.com

 

Sarah Roberts

Corporate Communications

Rolls-Royce plc

Tel: +44 (0) 7968 906469

Sarah.Roberts2@Rolls-Royce.com

 

Craig Taylor

Corporate Communications

Rolls-Royce plc

Tel: +44 (0)7807 969426

Craig.Taylor2@Rolls-Royce.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRQQLFFDFFEBBB
Date   Source Headline
11th May 20232:07 pmRNSResult of AGM
11th May 20239:14 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSAGM Statement and Trading Update
10th May 20234:00 pmRNSDirectorate change & withdrawal of AGM resolution
28th Apr 20233:44 pmRNSDirector/PDMR Shareholding
14th Apr 20239:30 amRNSDirector/PDMR Shareholding
11th Apr 20231:00 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSDirectorate Change
29th Mar 20239:34 amRNSDirector/PDMR Shareholding
21st Mar 20233:03 pmRNSDirector/PDMR Shareholding
17th Mar 20233:00 pmRNSDirector/PDMR Shareholding
10th Mar 20232:35 pmRNSDirector/PDMR Shareholding
8th Mar 20233:39 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:00 amRNSAnnual Report 2022 and Annual General Meeting 2023
1st Mar 20235:05 pmRNSHolding(s) in Company
28th Feb 20234:17 pmRNSDirector/PDMR Shareholding
24th Feb 202312:00 pmRNSDirector/PDMR Shareholding
23rd Feb 20237:00 amRNS2022 Full Year Results
10th Feb 20239:09 amRNSDirector Declaration
9th Feb 20239:30 amRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSDirectorate Change
31st Jan 20239:30 amRNSDirector/PDMR Shareholding
11th Jan 20233:50 pmRNSDirector/PDMR Shareholding
22nd Dec 202211:05 amRNSDirector/PDMR Shareholding
21st Dec 20229:37 amRNSDirectorate Change
8th Dec 20222:37 pmRNSDirector/PDMR Shareholding
5th Dec 20224:04 pmRNSDirector/PDMR Shareholding
29th Nov 20229:30 amRNSDirector/PDMR Shareholding
18th Nov 202210:07 amRNSHolding(s) in Company
14th Nov 202210:00 amRNSHolding(s) in Company
10th Nov 20229:15 amRNSHolding(s) in Company
9th Nov 20222:40 pmRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNSTrading Statement
31st Oct 20229:30 amRNSDirector/PDMR Shareholding
18th Oct 20222:45 pmRNSDirector Declaration
13th Oct 20223:15 pmRNSHolding(s) in Company
10th Oct 20225:11 pmRNSDirector/PDMR Shareholding
10th Oct 20229:30 amRNSHolding(s) in Company
5th Oct 20225:05 pmRNSHolding(s) in Company
28th Sep 202211:00 amRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSChange of Registrar
20th Sep 202211:45 amRNSExecutive Team Change
15th Sep 202210:54 amRNSRolls-Royce Completes Sale of ITP Aero
12th Sep 20229:00 amRNSHolding(s) in Company
7th Sep 20223:03 pmRNSDirector/PDMR Shareholding
30th Aug 202211:36 amRNSDirector/PDMR Shareholding
16th Aug 20229:00 amRNSHolding(s) in Company
10th Aug 20224:30 pmRNSHolding(s) in Company
10th Aug 202212:00 pmRNSDirector/PDMR Shareholding
9th Aug 20225:03 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.